Hbv and hdv: New treatments on the horizon

Valentina Zuccaro, Erika Asperges, Marta Colaneri, Lea Nadia Marvulli, Raffaele Bruno

Research output: Contribution to journalReview articlepeer-review

Abstract

Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection rep-resent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summa-rized the investigational therapies in the pipeline. Furthermore, we discussed some critical issues such as a “functional cure” approach, the futility of long-term NA therapy and the relevance of understanding drug actions and safety of antivirals, especially in special populations.

Original languageEnglish
Article number4054
JournalJournal of Clinical Medicine
Volume10
Issue number18
DOIs
Publication statusPublished - Sep 2021

Keywords

  • Antivirals
  • Functional cure
  • HBV
  • HDV
  • Pharmacology

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Hbv and hdv: New treatments on the horizon'. Together they form a unique fingerprint.

Cite this